Press release
Neuropathic Pain Market Expands as Demand for Effective Treatments Rises
Neuropathic Pain Market
The global neuropathic pain market is on a robust growth trajectory, with projections indicating a substantial increase in market size over the coming years. In 2023, the market was valued at approximately USD 8.13 billion and is anticipated to reach USD 11.91 billion by 2030, reflecting a Compound Annual Growth Rate (CAGR) of 5.6% during the forecast period.
Get a closer look at the game-changing products driving success: https://www.maximizemarketresearch.com/request-sample/34992/
Neuropathic Pain Market Competitive Landscape and Regional Demand
The market is characterized by the presence of several key players driving innovation and competition. Notable companies include Pfizer, Inc., Johnson & Johnson Services, Inc., Sanofi S.A., Eli Lilly and Company, GlaxoSmithKline PLC, Biogen Idec., Bristol-Myers Squibb, Baxter Healthcare Corporation, and Depomed, Inc.
Regionally, North America has historically held a dominant position in the neuropathic pain market, attributed to factors such as a growing elderly population and the prevalence of chronic diseases. However, the Asia-Pacific region is emerging as a significant growth area, with countries like China and India experiencing increased demand for neuropathic pain treatments due to rising healthcare awareness and improving medical infrastructure.
Explore detailed data and insights by viewing the sample: https://www.maximizemarketresearch.com/request-sample/34992/
Neuropathic Pain Market Country-Specific Developments
Neuropathic Pain Opportunities in Vietnam
Vietnam's mergers and acquisitions market is projected to experience a boom in 2025, creating potential opportunities for growth in the neuropathic pain sector.
ENGLISH.NEWS.CN
Neuropathic Pain Growth in Thailand
Thailand is witnessing an increase in healthcare investments, leading to improved access to pain management therapies and a growing market for neuropathic pain treatments.
Neuropathic Pain Trends in Japan
Japan's aging population is contributing to a higher incidence of neuropathic pain conditions, driving demand for effective management solutions and innovative therapies.
Neuropathic Pain Consolidation in South Korea
South Korea is experiencing consolidation in its healthcare sector, with mergers and acquisitions among medical device companies enhancing the availability of advanced neuropathic pain management devices.
Interested to take a sneak peek? Request a sample copy of the report to see what's inside: https://www.maximizemarketresearch.com/request-sample/34992/
Neuropathic Pain Updation in Singapore
Singapore's focus on medical research and development is leading to the introduction of updated neuropathic pain treatment protocols and cutting-edge therapies.
Neuropathic Pain Advances in the United States
The United States continues to lead in neuropathic pain research, with companies like Biogen Inc. developing non-opioid oral pain drugs, such as Vixotrigine, currently in Phase 2 trials for treating chronic painful neuropathy.
COHERENTMARKETINSIGHTS.COM
Neuropathic Pain Developments in China
China's rapidly aging population and increasing prevalence of chronic diseases are driving the neuropathic pain market, with a focus on developing affordable treatment options.
Neuropathic Pain Innovations in Europe
European countries are investing in research to develop innovative neuropathic pain therapies, with collaborations between pharmaceutical companies and research institutions leading to new treatment modalities.
Interested in market analysis? Don't miss the summary of the research report for valuable insights: https://www.maximizemarketresearch.com/market-report/global-neuropathic-pain-market/34992/
Neuropathic Pain Market Segmentation Analysis
by Drug Class
Antidepressants
Anticonvulsant
Opioids
Capsaicin
Others
The market is divided into drug classes such as antidepressants, anticonvulsants, opioids, capsaicin, and others. The anticonvulsant segment dominated the market in 2023 and is predicted to retain the highest Neuropathic Pain Market share during the forecast period. The anticonvulsant section of the neuropathic pain market refers to a class of drugs that are primarily used to treat seizures (epilepsy), but are also commonly prescribed to manage neuropathic pain. Anticonvulsants, often known as antiepileptic medicines (AEDs), work by regulating neuronal excitability and neurotransmitter activity in the central nervous system. Anticonvulsants work on a variety of molecular targets in the nervous system to stabilize neuronal membranes, prevent excessive neuronal activity, and diminish pain signal transmission.
by Indication
Diabetic Neuropathy
Spinal Stenosis
Chemotherapy-Induced Peripheral Neuropathy
Others
The market is divided into four segments based on indication: diabetic neuropathy, spinal stenosis, chemotherapy-induced peripheral neuropathy, and others. Diabetic neuropathy dominated the market in 2023 and is likely to continue to dominate the Neuropathic Pain Market during the forecast period. Diabetic neuropathy is a subset of the larger neuropathic pain sector that focuses on neuropathic pain problems that emerge as a result of diabetes. Diabetic neuropathy is nerve damage induced by prolonged exposure to high blood sugar levels (hyperglycemia) in people with diabetes.
by Distribution Channel
Hospital Pharmacies
Drugs Stores and Retail Pharmacies
Online Pharmacies
Key Recent Developments
In December 2021, Boston Scientific Corporation launched the WaveWriter Alpha Spinal Cord Stimulator Systems, offering advanced solutions for neuropathic pain management.
Biogen Inc. announced positive results from its Phase 2 CONVEY study of Vixotrigine, a non-opioid oral pain drug evaluated for the treatment of chronic painful neuropathy, in September 2021.
These developments underscore the dynamic nature of the neuropathic pain market, with continuous advancements aimed at improving patient outcomes and expanding treatment options globally.
Get Market Research Latest Trends
Global Automated Multi-Purpose Workstation https://www.maximizemarketresearch.com/market-report/global-automated-multi-purpose-workstation-market/100989/
Global Forensic Swabs Market https://www.maximizemarketresearch.com/market-report/global-forensic-swabs-market/111325/
Viable Tumor Samples Market https://www.maximizemarketresearch.com/market-report/global-viable-tumor-samples-market/95170/
Global Granulocyte Macrophage Colony Stimulating Factor Market https://www.maximizemarketresearch.com/market-report/global-granulocyte-macrophage-colony-stimulating-factor-market/69429/
Global Ankle-Brachial Index Measurement Market https://www.maximizemarketresearch.com/market-report/global-ankle-brachial-index-measurement-market/84325/
Global Rectopexy Mesh and Grafts Market https://www.maximizemarketresearch.com/market-report/global-rectopexy-mesh-and-grafts-market/94764/
Global Lesch-Nyhan Syndrome Market https://www.maximizemarketresearch.com/market-report/global-lesch-nyhan-syndrome-market/91116/
Zonisamide Market https://www.maximizemarketresearch.com/market-report/zonisamide-market/148295/
Global Patients Repositioning and Offloading Device Market https://www.maximizemarketresearch.com/market-report/patients-repositioning-and-offloading-device-market/123289/
Energy Supplements Market https://www.maximizemarketresearch.com/market-report/energy-supplements-market/193885/
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
sales@maximizemarketresearch.com
+91 96071 95908, +91 9607365656
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Neuropathic Pain Market Expands as Demand for Effective Treatments Rises here
News-ID: 3903189 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
VLSI Semiconductor Market : Opportunities for Investment and Mergers & Acquisiti …
The VLSI Semiconductor Market was valued at 60.71 Bn in 2024, and total Global VLSI Semiconductor Market revenue is expected to grow at a CAGR of 6.1% from 2025 to 2032, reaching nearly USD 97.49 Bn.
The VLSI (Very Large Scale Integration) Semiconductor market is witnessing a transformative shift as demand for highly integrated and efficient chips surges across multiple industries. VLSI technology enables the embedding of millions of transistors onto…
Neem Oil Market: Prospects for Growth in Developing Economies
Global Neem Oil Market size was valued at USD 2.08 Bn in 2023 and Neem Oil Market revenue is expected to reach USD 5.30 Bn by 2030, at a CAGR of 14.3 % over the forecast period (2024-2030).
The Neem Oil market is witnessing increasing adoption due to its natural pesticidal and medicinal properties, making it a preferred choice for organic farming and personal care products. Growing consumer awareness about chemical-free…
India PVC Pipes market : A Comprehensive Study of the Industry
The India PVC Pipes Market size was valued at USD 5.42 Billion in 2023 and the total India PVC Pipes revenue is expected to grow at a CAGR of 5.81% from 2024 to 2030, reaching nearly USD 8.05 Billion by 2030.
The India PVC Pipes Market is witnessing significant adoption across residential, commercial, and industrial segments due to the material's durability, corrosion resistance, and ease of installation. Increasing infrastructure development, including…
India Olive Oil: A Comprehensive Overview of the Industry's Players and Trends
The India Olive Oil Market size was valued at USD 88.75 Million in 2023 and the total India Olive Oil revenue is expected to grow at a CAGR of 16.2% from 2024 to 2030, reaching nearly USD 253.87 Million by 2030.
The India Olive Oil Market is witnessing a shift in consumer preferences, driven by growing awareness of health benefits associated with olive oil consumption. As more Indian households embrace Mediterranean…
More Releases for Neuropathic
Neuropathic Pain Management Market Size Analysis by Application, Type, and Regio …
USA, New Jersey- According to Market Research Intellect, the global Neuropathic Pain Management market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The neuropathic pain management market is experiencing consistent growth due to rising incidences of chronic conditions such as diabetes, cancer, and neurological disorders, which…
Neuropathic Pain Market New Therapeutic Developments and Treatments
On April 08, 2025, Exactitude Consultancy., Ltd. announces the release of the report "Global Neuropathic Pain Market 2025 by Manufacturers, Regions, Type and Application, Forecast to 2034". The report is a detailed and comprehensive analysis presented by region and country, type and application. As the market is constantly changing, the report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across…
Neuropathic Pain Market: Innovative Therapies Reshaping Chronic Pain Management
In recent years, the global Neuropathic Pain Market has witnessed a dynamic shift, influenced by changing consumer preferences, technological advancements, and a growing emphasis on sustainability. The Research report on Neuropathic Pain Market presents a complete judgment of the market through strategic insights on future trends, growth factors, supplier landscape, demand landscape, Y-o-Y growth rate, CAGR, pricing analysis. It also provides and a lot of business matrices including…
The increase in Neuropathic Ocular Pain Market Size is a direct consequence of i …
As per DelveInsight, the Neuropathic Ocular Pain Market is anticipated to grow in the coming years owing to the rise in the number of prevalent cases in the 7MM, the improvement in the research and development activities, and the launch of novel therapies in the Neuropathic Ocular Pain market. There are several key players involved in developing therapies for Neuropathic Ocular Pain, like Novartis, and others.
The Neuropathic Ocular Pain market…
Neuropathic Pain Market Growth Factors and Manufacturers
Neuropathic Pain Market 2022
Global Neuropathic Pain Market to Reach US$ 8.3 Bn by 2024 End.
Machine learning and artificial intelligence have been transforming the healthcare vertical since the last few years. AI-powered healthcare solutions are there to help the patients with automation of routine tasks and data analysis. Wearable technologies are a part of exclusive physiotherapy devices that are capable of tracking and analyzing specific movements of the patients. This would…
Global Neuropathic Pain Market Research Report Forecast to 2023
Neuropathic Pain Market 2020 comprises a detailed survey of the Neuropathic Pain Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025.
Global "Neuropathic Pain" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Neuropathic Pain market in terms of thriving companies, business methods, product values and pricing, revenue,…
